BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2013
View Archived Issues
Fedovapagon effectively reduces nocturia in men with BPH
Read More
ProQinase and Mercachem obtain E.U. funding
Read More
Israeli government renews funding to BioTime subsidiary
Read More
Medicago produces VLP vaccine candidate for H7N9 virus
Read More
Hisamitsu reports results from phase II study of terbinafine patch
Read More
Toyama Chemical obtains exclusive rights to solithromycin in Japan
Read More
Novel genomic model as a predictor of metastatic disease progression in prostate cancer
Read More
Potent novel anti-NS4B compounds from PTC Therapeutics
Read More
Improved pyrimidinediones for HIV infection described
Read More
Epigenetic modifications investigated in animal models of cancer
Read More
AbbVie and Alvine to collaborate on celiac disease therapeutic
Read More
Data monitoring board recommends continuation of phase III Livatag trial
Read More
FDA accepts supplemental BLA filing for Adcetris
Read More
TLR2 expression as a potential biomarker for clinical severity of atherosclerosis
Read More
Intercell and Vivalis to complete merger
Read More
Pearl Therapeutics begins phase III PT-003 program in moderate to severe COPD
Read More
Piramal Enterprises receives IND approval for P-11187
Read More
Rib-X begins phase III trial of Captisol-enabled delafloxacin
Read More
Sigma-Tau begins phase I study of heparanase inhibitor SST-000
Read More
Shionogi updates developments of fourth quarter of fiscal 2012
Read More
FDA approves Tarceva and accompanying test in NSCLC
Read More
Merck & Co. patents new OX1 and OX2 receptor antagonists
Read More
Novel arginase inhibitors disclosed by Mars, Inc.
Read More
BioTheryX synthesizes novel agents for cancer
Read More
BIKAM Pharmaceuticals presents new agents for ocular disorders
Read More